Skip to content

Preliminary Testing of a Novel Device to Detect Epileptic Seizures

Preliminary Testing of a Novel Device to Detect Epileptic Seizures

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT02286271
Acronym
PTEpD
Enrollment
117
Registered
2014-11-07
Start date
2015-01-20
Completion date
2016-12-31
Last updated
2017-05-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Epilepsy

Keywords

Seizure detection

Brief summary

Official statistics report around 1000 deaths due to epilepsy in the UK each year (Hanna et al 2002). Most of these deaths are un-witnessed and in many cases are believed to have been avoidable with timely assistance (Langan et al 2000). A major problem is detecting nocturnal seizures to allow body re-positioning, to maintain an open airway and to administer rescue medication. There are several seizure alarms commercially available but are often unreliable with many false alarms. The aim of this study is to investigate a novel seizure detection system with a unique algorithm.

Detailed description

Two duplicate novel medical devices conforming to safety regulation BS EN 60601 containing the unique algorithm will be evaluated in clinical trials at two hospitals over a 14 month period. Each device is time synchronised with an Electroencephalographic (EEG) videotelemetry system which is the gold standard in identifying different seizure types recording from scalp electrodes. The devices will be monitoring participants from 3 months and older (children and adults). The algorithm was created from results from a PhD where 527 seizures were categorised into different seizure types. Sensitivity of identifying seizures was 91% and specificity was 75% using an optimal trigger level and algorithm. This trial will investigate how reliable the algorithm is in practice and determine an optimal trigger level..

Interventions

None listed

Sponsors

NHS Lothian
CollaboratorOTHER_GOV
University of Edinburgh
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
3 Months to No maximum
Healthy volunteers
No

Inclusion criteria

* Frequent epileptic seizures 3 months and older Informed consent for participation

Exclusion criteria

* Infrequent seizures Attacks are of a non-epileptic nature Younger than 3 months Has an implantable device No informed consent.

Design outcomes

Primary

MeasureTime frameDescription
Reliable detection of epileptic seizures (Trigger level to be determined for total seizures)14 monthsTrigger level to be determined for total seizures

Secondary

MeasureTime frameDescription
Reliable detection of epileptic seizures (Trigger level to be determined for different types of seizures.)14 monthsTrigger level to be determined for different types of seizures.

Countries

United Kingdom

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026